Investor Ideas Adds New ASX Listed
#Cannabis and #Hemp #Stocks to Directory; @ASX
Point Roberts, WA, Delta BC – January 19, 2018 –
Investorideas.com, a global news source and investor resource covering actively
traded sectors announces this week’s additions to its cannabis /hemp stock directory (http://www.investorideas.com/Marijuana-Stocks/Stocks_List.asp) for investors following the sector.
Investorideas.com tracks cannabis and hemp publicly
traded companies on the TSX, TSX.V, CSE, OTC, NYSE, NASDAQ, ASX and global stock exchanges and makes ongoing
additions to its stock directories for its members. Free previews of all
directories are available to the public with full login access only accessible
to members
Read this news in full at http://www.investorideas.com/news/2018/cannabis/01192Stocks.asp
All of the recently added cannabis companies are
listed on the Australian Stock Exchange (ASX)
http://www.asx.com.au/. Stocks added include companies who are
medical cannabis producers, researchers and cultivators, provide hemp-based nutraceuticals, provide
hydroponic & cultivation equipment for the cannabis industry ,a maker of plant
care products, a pet pharma-cannabis company and finally, venture capital
investment firms which are currently investing in private sector cannabis
companies.
AusCann Group (ASX:AC8.AX) researches, develops,
cultivates, produces, and sells clinically validated cannabis medicines to
patients in Australia. The company has a strategic partnership with Tasmanian
Alkaloids Pty Ltd. AusCann Group Holdings Ltd is headquartered in Carabooda,
Australia.
MGC
Pharmaceuticals (ASX:
MXC.AX) operates as a medical and cosmetic
cannabis company in Australia and Slovenia. It is developing phytocannabinoid
as active pharmaceutical ingredients containing medicinal cannabis products.
The company is also developing product formulation groups, including MGCND00EP1
for neurological disorders; MGCON00CA1 for oncology treatment and side effects;
and MGCAU00SD1 for autoimmune treatments in inflammatory cases, as well as deep
skin relief products under the DermaPlus brand. In addition, it provides the
raw materials and matched genetics to treat patients that live with various
diseases.
Creso Pharma (ASX:
CPH.AX) develops and commercializes
cannabis and hemp based nutraceutical products for human and animal health. It
offers products for various age groups to accommodate a range of dietary
requirements that are based non-animal derived gums, allowing buccal absorption
of the cannabinoids. The company is also developing products based on BioLingus
technology platform that uses micro-encapsulation technology for sublingual
delivery of bio-active molecules such as proteins, peptides, and small
molecules; and bioavailable enteric-coated tablets based on mesoporous silica
gel.
Algae.Tec (ASX:
AEB.AX) is a specialist producer, focused
on developing technology that captures waste carbon dioxide to produce
commercial quantities of a range of plant derived products for supply to three
key markets: Medicinal cannabis, Algae-based nutraceuticals and Animal feed and
aquaculture markets.
Queensland
Bauxite (ASX:
QBL.AX) engages in the exploration and
development of bauxite tenements in Queensland and New South Wales. It operates
through three segments: Mining Exploration and Evaluation, Medical Cannabis,
and Corporate. The company’s flagship project is the South Johnstone bauxite
deposit located in Northern Queensland. It also holds 100% interest in the
Pilbara gold project that covers an area of approximately 200 square kilometers
in Queensland. In addition, Queensland Bauxite Limited engages in the hemp and
medical cannabis business.
The Hydroponics Company (ASX:
THC.AX) focuses on the manufacture and
distribution of hydroponics equipment, materials, and nutrients for cannabis
cultivation and processing worldwide. Its products include extraction bags to
filter plant resins without using chemicals; horticultural lighting products;
lighting relays; trimmers for the removal of protruding leaves and roots, as
well as for the preparation of plants for essential oils; multi-directional
oscillating wall-mount fans for air circulation and coverage; ceramic metal
halide lamps; elemental controls for temperature control for commercial
hydroponic systems; and rack drying systems. It also engages in the hydroponic
greenhouse design and construction activities; and development and delivery of medicinal
cannabis.
EVE
Investments (ASX:
EVE.AX) is a venture capital firm
specializing in startup investments in technology sector. The firm prefers to
invests in Australia. Hemp: Eve Investments holds a 50% interest in Meluka
Health. Meluka Health is a wellness and nutrition company that develops and
sells its naturally derived, organic and ecologically pure products created
using its old growth Australian Melaleuca tea tree plantation which are worldly
acclaimed for their medicinal activity. Meluka Health is currently focused on
producing high quality organic medicinal honey and the development of a bee
health tonic. Products - Hemp Seed Honey –incorporating the health benefits of
hemp seed which has a concentrated balance of proteins, essential fats,
vitamins and enzymes combined with a relative absence of sugar, starches and
saturated fats and combined with Meluka Honey to deliver an exception flavour
profile; Medicinal cannabis honey – a premium medicinal honey product produced
by by Bees harvesting on cannabis plants
Chapmans
Limited (ASX:
CHP.AX) is a venture capital firm
specializing in early- stage, mature investments, special situation companies,
growth capital investments in public and private companies. CANNABIS: MJ Life
Sciences Pty Ltd - MJLS is an Australian special-purpose company established
with the aim of becoming a leading global medicinal cannabis holding and
investment company. MJLS is a direct investor in Caziwell Inc., owner of the
established North American medicinal cannabis brand and business Aunt Zelda’s,
with convertible note rights of up to 49.99% in Caziwell Inc. Chapmans views
the opportunity to invest directly in MJLS, and have direct exposure to its
future investments in the rapidly growing global medicinal cannabis sector, as
being strategically advantageous and consistent with it’s high conviction and
capital growth investment philosophy.MJLS expects to secure further compelling
medicinal cannabis assets in the near term and list on the ASX by IPO or RTO in
2018 .
eSense-Lab (ASX:
ESE.AX) a life sciences company,
specializes in the commercialization of the phytochemical profiling of plants.
Its technology combines genetics, mRNA, protein expression, and phytochemical
profiles to generate a comprehensive model of rare or high value plants. The
company’s product is reconstructed cannabis Terpene Profiles. esense-Lab Ltd.
was incorporated in 2016 and is based in Nes Tziona, Israel.
Roto-Gro International (ASX:
RGI.AX) holds license for and sells
automated rotary hydroponic advanced garden systems (Roto-Gro System) in
Australia and Canada. The Roto-Gro System is able to produce uniform high
quality medicinal cannabis at a reasonable cost allowing the Company to realise
the burgeoning medicinal cannabis market in the western world.
CannPal Animal
Therapeutics (ASX:
CP1.AX) a pet pharmaceutical company,
focuses on research, development, and commercialization of regulatory approved
medicines using compounds derived from the cannabis plant for cats, dogs, and
horses in Australia.
The complete marijuana/hemp stock list available for purchase in a PDF
format:
Investorideas.com tracks companies in high profile
trading sectors and makes ongoing additions to its stock directories for each
sector. Listing for the stock directories include companies on the
TSX, OTC, NYSE, NASDAQ and global stock exchanges.
Investorideas.com global stock directories are part
of the membership program on the site, accessed either by login and password or
available in PDF format. The directories include stocks trading on the
TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving
retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About
Investorideas.com - News that Inspires Big Ideas
Investorideas.com
is a meeting place for global investors, featuring news, stock directories,
video, podcasts, company profiles,
interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp
content now includes: http://cannabisstocknews.blogspot.com on
Blogger.com: the Investorideas.com news and stock directory pages, a cannabis
investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Services for Publicly traded and private companies: http://www.investorideas.com/Investors/Services.asp
Investorideas is Listed on The Canadian Securities Exchange
(CSE) Directory of Service Providers
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and distribution,social
media and marketing, content creation and more. Contact each company directly
regarding content and press release questions. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment